Pharmabiz
 

Strand signs distribution pact with InterFocus for European market

Our Bureau, BangaloreSaturday, April 10, 2004, 08:00 Hrs  [IST]

Strand Genomics, a global life sciences informatics company has entered into a distribution agreement with InterFocus to sell Avadis, Strand's flagship product for microarray data analysis and visualization. As per the agreement InterFocus will represent Strand in the United Kingdom, France, Germany, Austria and Switzerland to market Avadis. Avadis is currently one of the best solutions in data mining techniques and software engineering to microarray gene expression analysis. It combines deep scalable analysis algorithms with a powerful visualization engine and the ability to access data and annotations. With a unique system, the product stems from its depth in all three dimensions that facilitate discovery - access, visualization and analysis, says the company sources. The product has also got easy to use wizards and provides a wide range of clustering techniques and statistical tests that make up the complete analysis toolset. It is available in three editions - explorer, prophetic and pride. According to Dr. Vijay Chandru chief executive officer, Strand Genomics, InterFocus is now well established in Europe and has a wide reach that will help the product penetrate the European market and gain a significant market share. Commenting on the distribution pact with Strand, Marcus Cannon, sales director, InterFocus, said that the partnership with InterFocus would help Strand Genomics to gain a significant market share and in a competitive scenario, Avadis offers value and this will be an important driving force in Europe.

 
[Close]